- ALR Technologies ( OTCQB:ALRT ) has received manufacturing approval from Infinovo Medical to place the first purchase order for the GluCurve Pet CGM with an expected delivery date of October 2022.
- Both parties agreed to let that agreement terminate and are now working on completing a new agreement under the same terms, extending the closing condition for ALRT to enter into a binding sales and distribution agreement for GluCurve to August 31, 2022.
- The GluCurve Pet CGM is the first and only continuous glucose monitoring system for diabetic cats and dogs.
- “The last step in their due diligence process is to evaluate the GluCurve Pet CGM internally by using it on their own sample of customers and their respective pets.” said Joe Stern, Head of Animal Health at ALRT.
For further details see:
ALR Technologies announces first shipment of GluCurve Pet CGMs expected in October